Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3/12/25 21:36 | 3/10/25 | IRON | Health | Drug | Pharmaceutical Preparations | Ashiya Mona | MA | D | 1 | S.m | -16,966 | 54.31 | 0 | -312 | 194 | I | ||||||||||||||||
3/12/25 21:34 | 3/10/25 | IRON | Health | Drug | Pharmaceutical Preparations | Orbimed Advisors LLC | NY | D | 1 | S.m | -16,966 | 54.31 | 0 | -312 | 194 | I | ||||||||||||||||
2/20/25 19:38 | 2/18/25 | IRON | Health | Drug | Pharmaceutical Preparations | Stephenson Pamela | MA | O | Chief Co | 1 | S | -171 | 54.58 | 0 | -3 | 70 | D | |||||||||||||||
2/20/25 19:36 | 2/18/25 | IRON | Health | Drug | Pharmaceutical Preparations | Khara Rahul | MA | O | GC | 5 | S.d | -1,171 | 37.58 | 0 | -31 | 38 | D | |||||||||||||||
2/20/25 19:33 | 2/18/25 | IRON | Health | Drug | Pharmaceutical Preparations | Savage William Jacob | MA | O | Chief Me | 2 | S.d | -105 | 14.19 | 0 | -7 | 70 | D | |||||||||||||||
2/20/25 19:31 | 2/18/25 | IRON | Health | Drug | Pharmaceutical Preparations | Yu Jonathan Yen-Wen | MA | O | COO | 1 | S | -88 | 54.58 | 0 | -2 | 41 | D | |||||||||||||||
2/20/25 19:29 | 2/18/25 | IRON | Health | Drug | Pharmaceutical Preparations | Franchi Jean M. | MA | O | CFO | 1 | S | -171 | 54.58 | 0 | -3 | 70 | D | |||||||||||||||
2/20/25 19:27 | 2/18/25 | IRON | Health | Drug | Pharmaceutical Preparations | Quisel John D | MA | DO | CEO | 7 | S.dm | -3,410 | 31.92 | 0 | -107 | 155 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |